The Global Craniomaxillofacial Devices Market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 2422 million in 2018 and is projected to register a CAGR of 7.2% over the forecast period.
The increasing participation of key players is one of the key factors driving the craniomaxillofacial devices market. In 2019, Kelyniam Global (KLYG) received premarket FDA approval for unique modifications to their PEEK cranio-maxillofacial implant product line.
Various other factors such as the acceptance of craniomaxillofacial devices market in ambulatory settings, increasing geriatric population, untapped emerging markets, rise in regulatory approvals, and growing demand for bioresorbable devices are also expected to propel the growth of the market.
Some of the key players in the global CMF devices market are Aesculap Implant System LLP, Johnson Johnson, Kanghui Orthopedic, OsteoMed, KLS Martin, MATRIX SURGICAL USA, Integra Lifesciences Corporation, Medtronic, Medartis AG, Stryker, Corporation, TMJ Concepts, W.L. Gore and Associates, Zimmer Biomet Inc., and others.
The global craniomaxillofacial devices market is segmented based on product, material, application, end user, and region.
The global market for craniomaxillofacial (CMF) devices, by product, is segmented into cranial flap fixation, craniomaxillofacial fixation (CMF) distraction, temporomandibular joint replacement
thoracic fixation, bone graft substitute, CMF plate, and screw fixation, and dural repair. The dural repair segment is further classified as dural sealants and dural substitutes.
Based on material, the market is segmented into metals and alloys, bioabsorbable, ceramics, polymers, and others.
Based on application, the market is segmented into neurosurgery, ENT, orthognathic dental surgery, plastic surgery, and others.
Based on end user, the market is segmented into hospitals, ambulatory surgical centers, and others.
The ambulatory surgical centers segment is expected to witness the fastest growth over the forecast period due to rising acceptance of craniomaxillofacial (CMF) devices in ambulatory settings.
In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and African region.
The CMF devices market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European CMF devices market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The CMF devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Craniomaxillofacial (CMF) Devices market in the Middle East Africa has been segmented into the Middle East and Africa.
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.